The global protein purification and isolation market is accounted to reach USD 10,328.02 million by 2025 from USD 5,580.31 million in 2017, at a CAGR of 8.1% in the forecast period 2018 to 2025.
The major factors contributing to the growth of the market includes factors such as increasing importance of identification of new ligands, technological development towards rapid purification kits, paradigm shift towards automated instrumentation for protein purification and increasing growth of proteomics market.
The key market players for global protein purification and isolation market are listed below:
- ThermoFisher Scientific Inc.
- Merck KGaA
- GE Healthcare
- QIAGEN
- BIO-RAD LABORATORIES, INC.
- Agilent
- Promega Corporation
- Purolite
- BioVision, Inc.
- Expedeon Ltd.
The market is further segmented into:
- Technology
- Product Type
- Application
- End-User
- Geography
The global protein purification & isolation market is segmented on the basis of technology into ultrafiltration, precipitation, preparative chromatography techniques, electrophoresis, western blotting (immunoblotting), dialysis and diafiltration and centrifugation. In 2018, precipitation is expected to dominate the protein purification & isolation market with 25.9% market share and is expected to reach USD 2,850.93 million by 2025, growing at a CAGR of 9.1% in the forecast period 2018 to 2025. The preparative chromatography techniques are further sub segmented into affinity chromatography, ion exchange chromatography, reverse phase chromatography, hydrophobic interaction chromatography (HIC) and size exclusion chromatography (gel filtration). The affinity chromatography is further sub segmented into immobilized metal ion affinity chromatography, immunoaffinity chromatography and bead based chromatography. The electrophoresis is further sub segmented into gel electrophoresis, isoelectric focusing and capillary electrophoresis.
The global protein purification & isolation market is segmented on the basis of product type into instruments and consumables. In 2018, instruments is expected to dominate the protein purification & isolation market with 63.7% market share and is expected to reach USD 6,678.45 million by 2025, growing at the highest CAGR of 8.3% in the forecast period 2018 to 2025. The instruments are further sub segmented into purification systems and software. The consumables are further sub segmented into kits, reagents, columns, resins, beads and others.
The global protein purification & isolation market is segmented on the basis of application into drug screening, target identification, biomarker discovery, protein-protein interaction studies, protein therapeutics and disease diagnosis and monitoring. In 2018, drug screening is expected to dominate the protein purification & isolation market with 25.1% market share and is expected to reach USD 2,644.53 million by 2025, growing at a CAGR of 8.4% in the forecast period 2018 to 2025.
The global protein purification & isolation market is segmented on the basis of end user into biotech & pharma industries, contract research organization, academic research institutes, hospital and diagnosis centers. In 2018, biotech & pharma industries is expected to dominate the protein purification & isolation market with 34.3% market share and is expected to reach 3,670.32 million by 2025, growing at the highest CAGR of 8.7% in the forecast period 2018 to 2025.
Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.
Based on geography, the global protein purification & isolation market is segmented into geographical regions, such as,
- North- America,
- South America
- Europe
- Asia-Pacific
- Middle East and Africa
Covered in this report:
The report covers the present scenario and the growth prospects of the global protein purification & isolation market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
TABLE OF CONTENTS
1. INTRODUCTION
- 1.1. OBJECTIVES OF THE STUDY
- 1.2. MARKET DEFINITION
- 1.3. OVERVIEW OF GLOBAL PROTEIN PURIFICATION & ISOLATION MARKET
- 1.4. CURRENCY AND PRICING
- 1.5. LIMITATION
- 1.6. MARKETS COVERED
2. MARKET SEGMENTATION
- 2.1. MARKETS COVERED
- 2.2. GEOGRAPHIC SCOPE
- 2.3. YEARS CONSIDERED FOR THE STUDY
- 2.4. CURRENCY AND PRICING
- 2.5. RESEARCH METHODOLOGY
- 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
- 2.7. SECONDARY SOURCES
- 2.8. ASSUMPTIONS
3. MARKET OVERVIEW
- 3.1. DRIVERS
- 3.1.1. INCREASING IMPORTANCE OF IDENTIFICATION OF NEW LIGANDS
- 3.1.2. TECHNOLOGICAL DEVELOPMENT TOWARDS RAPID PURIFICATION KITS
- 3.1.3. PARADIGM SHIFT TOWARDS AUTOMATED INSTRUMENTATION FOR PROTEIN PURIFICATION
- 3.1.4. INCREASING GROWTH OF PROTEOMICS MARKET
- 3.2. RESTRAINTS
- 3.2.1. COST OF EQUIPMENT HINDER THE GROWTH OF THE MARKET IN EMERGING ECONOMIES
- 3.3. OPPORTUNITIES
- 3.3.1. GROWING REVENUE POCKETS IN EMERGING ECONOMIES
- 3.4. CHALLENGES
- 3.4.1. HIGH-COMPETITIVE INTENSITY
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL PROTEIN PURIFICATION & ISOLATION MARKET,
BY TECHNOLOGY 60
- 6.1. OVERVIEW
- 6.2. PRECIPITATION
- 6.3. CENTRIFUGATION
- 6.4. PREPARATIVE CHROMATOGRAPHY TECHNIQUES
- 6.4.1. AFFINITY CHROMATOGRAPHY
- 6.4.1.1. IMMOBILIZED METAL ION AFFINITY CHROMATOGRAPHY (IMAC)
- 6.4.1.2. IMMUNOAFFINITY CHROMATOGRAPHY
- 6.4.1.3. BEAD BASED CHROMATOGRAPHY
- 6.4.2. ION EXCHANGE CHROMATOGRAPHY (IEC)
- 6.4.3. REVERSE PHASE CHROMATOGRAPHY
- 6.4.4. HYDROPHOBIC INTERACTION CHROMATOGRAPHY (HIC)
- 6.4.5. SIZE EXCLUSION CHROMATOGRAPHY (GEL FILTRATION)
- 6.5. ELECTROPHORESIS
- 6.5.1. GEL ELECTROPHORESIS
- 6.5.2. ISOELECTRIC FOCUSING (IEF)
- 6.5.3. CAPILLARY ELECTROPHORESIS
- 6.6. ULTRAFILTRATION
- 6.7. WESTERN BLOTTING (IMMUNOBLOTTING)
- 6.8. DIALYSIS AND DIAFILTRATION
7. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET,
BY PRODUCT TYPE 76
- 7.1. OVERVIEW
- 7.2. INSTRUMENTS
- 7.2.1. PURIFICATION SYSTEMS
- 7.2.2. SOFTWARES
- 7.3. CONSUMABLES
- 7.3.1. KITS
- 7.3.2. REAGENTS
- 7.3.3. COLUMNS
- 7.3.4. RESINS
- 7.3.5. BEADS
- 7.3.6. OTHERS
8. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET,
BY APPLICATION 84
- 8.1. OVERVIEW
- 8.2. DRUG SCREENING
- 8.1. TARGET IDENTIFICATION
- 8.2. BIOMARKER DISCOVERY
- 8.3. PROTEIN-PROTEIN INTERACTION
- 8.4. PROTEIN THERAPEUTICS
- 8.5. DISEASE DIAGNOSIS AND MONITORING
9. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET,
BY END USER 93
- 9.1. OVERVIEW
- 9.2. BIOTECH & PHARMA INDUSTRIES
- 9.3. CONTRACT RESEARCH ORGANIZATION
- 9.4. ACADEMIC RESEARCH INSTITUTES
- 9.5. HOSPITAL AND DIAGNOSIS CENTERS
10. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET,
BY GEOGRAPHY 100
- 10.1. OVERVIEW
- 10.2. NORTH AMERICA
- 10.2.1. U.S.
- 10.2.2. CANADA
- 10.2.3. MEXICO
- 10.3. EUROPE
- 10.3.1. GERMANY
- 10.3.2. FRANCE
- 10.3.3. U.K.
- 10.3.4. ITALY
- 10.3.5. SPAIN
- 10.3.6. SWITZERLAND
- 10.3.7. NETHERLANDS
- 10.3.8. TURKEY
- 10.3.9. BELGIUM
- 10.3.10. RUSSIA
- 10.3.11. REST OF EUROPE
- 10.4. ASIA-PACIFIC
- 10.4.1. JAPAN
- 10.4.2. CHINA
- 10.4.3. INDIA
- 10.4.4. SOUTH KOREA
- 10.4.5. AUSTRALIA
- 10.4.6. SINGAPORE
- 10.4.7. THAILAND
- 10.4.8. MALAYSIA
- 10.4.9. INDONESIA
- 10.4.10. PHILLIPPINES
- 10.4.11. REST OF ASIA-PACIFIC
- 10.5. SOUTH AMERICA
- 10.5.1. BRAZIL
- 10.5.2. REST OF SOUTH AMERICA
- 10.6. MIDDLE EAST AND AFRICA
- 10.6.1. SOUTH AFRICA
- 10.6.2. REST OF MIDDLE EAST AND AFRICA
11. GLOBAL PROTEIN PURIFICATION AND ISOLATION MARKET,
COMPANY LANDSCAPE 325
- 11.1. COMPANY SHARE ANALYSIS: GLOBAL
- 11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
- 11.3. COMPANY SHARE ANALYSIS: EUROPE
- 11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12. COMPANY PROFILES
- 12.1. THERMO FISHER SCIENTIFIC INC.
- 12.1.1. COMPANY OVERVIEW
- 12.1.2. THERMO FISHER SCIENTIFIC INC. :REVENUE ANALYSIS
- 12.1.3. PRODUCT PORTFOLIO
- 12.1.4. RECENT DEVELOPMENTS
- 12.2. SIGMA ALDRICH (A SUBSIDIARY OF MERCK KGAA)
- 12.2.1. COMPANY OVERVIEW
- 12.2.2. MERCK KGAA: REVENUE ANALYSIS
- 12.2.3. PRODUCT PORTFOLIO
- 12.2.4. RECENT DEVELOPMENTS
- 12.3. QIAGEN
- 12.3.1. COMPANY OVERVIEW
- 12.3.2. QIAGEN: COMPANY OVERVIEW
- 12.3.3. PRODUCT PORTFOLIO
- 12.3.4. RECENT DEVELOPMENTS
- 12.4. GE HEALTHCARE
- 12.4.1. COMPANY OVERVIEW
- 12.4.2. GE HEALTHCARE: REVENUE ANALYSIS
- 12.4.3. PRODUCT PORTFOLIO
- 12.4.4. RECENT DEVELOPMENTS
- 12.5. BIO-RAD LABORATORIES, INC.
- 12.5.1. COMPANY OVERVIEW
- 12.5.2. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
- 12.5.3. PRODUCT PORTFOLIO
- 12.5.4. RECENT DEVELOPMENTS
- 12.6. AGILENT TECHNOLOGIES
- 12.6.1. COMPANY OVERVIEW
- 12.6.2. AGILENT TECHNOLOGIES:REVENUE ANALYSIS
- 12.6.3. PRODUCT PORTFOLIO
- 12.6.4. RECENT DEVELOPMENTS
- 12.7. PROMEGA CORPORATION
- 12.7.1. COMPANY OVERVIEW
- 12.7.2. PROMEGA CORPORATION: COMPANY SNAPSHOT
- 12.7.3. PRODUCT PORTFOLIO
- 12.7.4. RECENT DEVELOPMENTS
- 12.8. PUROLITE
- 12.8.1. COMPANY OVERVIEW
- 12.8.2. PUROLITE:COMPANY SNAPSHOT
- 12.8.3. PRODUCT PORTFOLIO
- 12.8.4. RECENT DEVELOPMENTS
- 12.9. BIOVISION INC.
- 12.9.1. COMPANY OVERVIEW
- 12.9.2. BIOVISION, INC.: COMPANY SNAPSHOT
- 12.9.3. PRODUCT PORTFOLIO
- 12.9.4. RECENT DEVELOPMENTS
- 12.10. EXPEDEON LTD.
- 12.10.1. COMPANY OVERVIEW
- 12.10.2. EXPEDEON LTD. : COMPANY SNAPSHOT
- 12.10.3. PRODUCT PORTFOLIO
- 12.10.4. RECENT DEVELOPMENTS
- 12.11. NORGEN BIOTEK CORP.
- 12.11.1. COMPANY OVERVIEW
- 12.11.2. NORGEN BIOTEK CORP.: COMPANY SNAPSHOT
- 12.11.3. PRODUCT PORTFOLIO
- 12.11.4. RECENT DEVELOPMENTS
- 12.12. PERKINELMER INC.
- 12.12.1. COMPANY OVERVIEW
- 12.12.2. PERKINELMER INC.: REVENUE ANALYSIS
- 12.12.3. PRODUCT PORTFOLIO
- 12.12.4. RECENT DEVELOPMENTS
- 12.13. ABCAM PLC
- 12.13.1. COMPANY OVERVIEW
- 12.13.2. ABCAM PLC: REVENUE ANALYSIS
- 12.13.3. PRODUCT PORTFOLIO
- 12.13.4. RECENT DEVELOPMENTS
- 12.14. BERTIN BIOREAGENT
- 12.14.1. COMPANY OVERVIEW
- 12.14.2. BERTIN BIOREAGENT: COMPANY SNAPSHOT
- 12.14.3. PRODUCT PORTFOLIO
- 12.14.4. RECENT DEVELOPMENTS
- 12.15. ADVANSTA INC.
- 12.15.1. COMPANY OVERVIEW
- 12.15.2. ADVANSTA INC.: COMPANY SNAPSHOT
- 12.15.3. PRODUCT PORTFOLIO
- 12.15.4. RECENT DEVELOPMENTS
13. RELATED REPORTS
比較リスト
